Navigation Links
SINOL USA, Inc. and Strategic Pharmaceutical Advisors, Inc. to Enter a Marketing Agreement for SINOL Nasal Spray
Date:7/1/2008

Strategic Pharmaceutical Advisors (SRxA) and Sinol USA, Inc. announced the signing of a Memorandum of Understanding signifying their intent to enter into a marketing agreement for SINOL Nasal Spray, an all natural, capsaicin-based product for fast relief from allergy and sinus congestion and headaches of all types.

Washington, DC, and Newtown, CT (PRWEB) July 1, 2008 -- Strategic Pharmaceutical Advisors (SRxA) and Sinol USA, Inc., announced today the signing of a Memorandum of Understanding signifying their intent to enter into a marketing agreement for SINOL Nasal Spray. Under the proposed terms of the agreement SRxA will lead the worldwide educational and information support of SINOL Nasal Spray to professional and consumer audiences.

Headquartered in Newtown Connecticut, Sinol USA Inc. is a healthcare company dedicated to the Development of products using all natural ingredients. Available without a prescription, SINOL Nasal Spray formulations use clean, old fashioned ingredients for fast relief from allergy and sinus congestion and headaches of all degrees and types.

SRxA is a health education and strategic planning firm with world-renowned physicians as its partners and advisors. As part of this agreement, SRxA will develop programming tailored to the education of professional and consumer audiences and deliver it in a variety of media appropriate for each target audiences. Strategic Pharmaceutical Advisors is headquartered in Washington, DC, with offices in London and Hong Kong.

In announcing this collaboration, Paul Carpenter, Chief Executive Officer of Sinol USA, Inc. noted, "SINOL Nasal Sprays have caught the attention of U.S. medical practitioners in a very short period of time. With this collaboration, we now look forward to expanding our US base and reaching an international physician audience through the proven expertise and global sphere of influence of Strategic Pharmaceutical Advisors."

Dr. Christos S. Efessiou, Strategic Pharmaceutical Advisors' Chief Executive Officer, commented "The option of providing the public with an all natural, non-prescription alternative for relief from allergy-related congestion and headaches, impressed our Team enough to seek an active partnership in SINOL. My colleagues and I are excited at the possibilities that this partnership will offer to healthcare professionals and to allergy and headache sufferers."

Sinol USA is presently working with Strategic BioSciences, a SRxA affiliate, in a pioneering new product reformulation agreement which is expected to offer significant advantages to SINOL users. The two companies expect to announce this agreement in the near future.

For more information please visit: www.SRxA.com and www.sinolusa.com.

# # #


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
2. Honour Healthcare and River Logic Deliver Comprehensive Integrated Business Planning Solution Through Strategic Alliance
3. American Well and Microsoft Enter Into a Strategic Collaboration to Bring Healthcare to Peoples Homes
4. StayWell Custom Communications Announces Strategic Alliance With HealthMedia
5. TetraQ and Q-Pharm form strategic alliance
6. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
7. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
8. Nonin(R) Medical Announces Strategic Relationship With Microsoft and its Microsoft HealthVault Platform
9. Xceed Molecular Licenses Signature from Moffitt Cancer Center and Adds Moffitt to Strategic Collaborator Program
10. Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics
11. Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: